KAPPOS, Ludwig, Ralf GOLD, David H. MILLER, David G. MACMANUS, Eva HAVRDOVÁ, Volker LIMMROTH, Chris H. POLMAN, Klaus SCHMIERER, Tarek A. YOUSRY, Minhua YANG, Mefkure ERAKSOY, Eva MELUZÍNOVÁ, Ivan REKTOR, Katherine D. DAWSON, Alfred W. SANDROCK and Gilmore N. O'NEILL. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Online. Lancet. 2008, vol. 25, 372 (9648), p. 1463-1472., 10 pp. ISSN 0140-6736. [citováno 2024-04-23]
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Name in Czech Účinnost a bezpečnost orálního fumaráta na atakovité formě sklerozy multiplex - multicentrická randomizovaná studie fáze II b
Authors KAPPOS, Ludwig (756 Switzerland), Ralf GOLD (276 Germany), David H. MILLER (826 United Kingdom of Great Britain and Northern Ireland), David G. MACMANUS (826 United Kingdom of Great Britain and Northern Ireland), Eva HAVRDOVÁ (203 Czech Republic), Volker LIMMROTH (276 Germany), Chris H. POLMAN (528 Netherlands), Klaus SCHMIERER (826 United Kingdom of Great Britain and Northern Ireland), Tarek A. YOUSRY (826 United Kingdom of Great Britain and Northern Ireland), Minhua YANG (840 United States of America), Mefkure ERAKSOY (792 Turkey), Eva MELUZÍNOVÁ (203 Czech Republic), Ivan REKTOR (203 Czech Republic, guarantor), Katherine D. DAWSON (840 United States of America), Alfred W. SANDROCK (840 United States of America) and Gilmore N. O'NEILL (840 United States of America)
Edition Lancet, 2008, 0140-6736.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 28.409
RIV identification code RIV/00216224:14110/08:00027535
Organization unit Faculty of Medicine
UT WoS 000260801300023
Keywords in English Multiple sclerosis; multicentre; randomised; placebo
Tags multicentre, Multiple sclerosis, Placebo, randomised
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Ivan Rektor, CSc., učo 1073. Changed: 18/6/2009 09:12.
Abstract
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Abstract (in Czech)
Účinnost a bezpečnost orálního fumaráta na atakovité formě sklerozy multiplex - multicentrická randomizovaná studie fáze II b
Links
MSM0021622404, plan (intention)Name: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS
Investor: Ministry of Education, Youth and Sports of the CR, The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.
PrintDisplayed: 23/4/2024 20:28